
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Liothyronine Sodium
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase II
Sponsor : Attikon Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection
Details : Liothyronine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Lung Diseases.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
April 16, 2020
Lead Product(s) : Liothyronine Sodium
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Sponsor : Attikon Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Chloroquine Phosphate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Athens General Hospital Hippokrateio | Sotiria Thoracic Diseases Hospital | Sismanoglio General Hospital | Divine Providence Hospital Pammakaristos | AHEPA University Hospital | University Hospital of Ioannina | Corfu General Hospital Agia Irini
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Unikinon (Chloroquine Phosphate) is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Pneumonia, Viral.
Product Name : Unikinon
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 14, 2020
Lead Product(s) : Chloroquine Phosphate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Athens General Hospital Hippokrateio | Sotiria Thoracic Diseases Hospital | Sismanoglio General Hospital | Divine Providence Hospital Pammakaristos | AHEPA University Hospital | University Hospital of Ioannina | Corfu General Hospital Agia Irini
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Study Phase : Phase IV
Sponsor : Attikon Hospital | Amalia Fleming Prefecture General Hospital of Melissia | G.Gennimatas General Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ferrous Sulfate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Anemia, Iron-Deficiency.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
May 15, 2018
Lead Product(s) : Ferrous Sulfate
Therapeutic Area : Hematology
Highest Development Status : Phase IV
Sponsor : Attikon Hospital | Amalia Fleming Prefecture General Hospital of Melissia | G.Gennimatas General Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Paracetamol
Therapeutic Area : Immunology
Study Phase : Phase IV
Sponsor : Attikon Hospital | University Hospital of Patras | University Hospital of Crete | Thriasio General Hospital of Elefsina | General Hospital of Thessaloniki Ippokratio | General Hospital of Chalkida
Deal Size : Inapplicable
Deal Type : Inapplicable
A New Formulation of Intravenous Paracetamol for Fever Management
Details : Acetaminophen is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Fever.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 05, 2014
Lead Product(s) : Paracetamol
Therapeutic Area : Immunology
Highest Development Status : Phase IV
Sponsor : Attikon Hospital | University Hospital of Patras | University Hospital of Crete | Thriasio General Hospital of Elefsina | General Hospital of Thessaloniki Ippokratio | General Hospital of Chalkida
Deal Size : Inapplicable
Deal Type : Inapplicable
